2024 DEA cannabis rescheduling ruling delayed, causing market downturn and stock declines.

The U.S. Drug Enforcement Administration (DEA) delayed its final ruling on cannabis rescheduling until after the 2024 presidential election, causing a market downturn in the cannabis sector and significant declines in major cannabis stocks like Curaleaf Holdings, Cresco Labs, and Cansortium. The DEA set an Administrative Law Judge (ALJ) hearing for December 2024, increasing market uncertainty. Investors should be prepared for potential downturns in cannabis stock prices and consider risks and rewards before making investment decisions. The outcome of the 2024 election will significantly impact cannabis rescheduling and the future of the industry.

August 26, 2024
70 Articles